Skip to main content Accessibility help

Overexpression of cyclin E messenger ribonucleic acid in nasopharyngeal carcinoma correlates with poor prognosis

  • M-T Ko (a1), C-Y Su (a1), S-C Huang (a2), C-H Chen (a1) and C-F Hwang (a1)...



S-phase kinase-associated protein 2 is required for the degradation of p27 protein, which is a negative regulator of cyclin E/cyclin-dependent kinase 2 complex. The present study examined the expression of cyclin E, S-phase kinase-associated protein 2 and p27 protein in nasopharyngeal carcinoma.


Tissue from 35 cases of nasopharyngeal carcinoma and 10 normal nasopharyngeal tissue samples underwent reverse polymerase chain reaction to detect messenger ribonucleic acid. Immunohistochemical analysis was performed on 29 nasopharyngeal tissue samples in order to detect protein expression.


Messenger ribonucleic acid expression in the nasopharyngeal carcinoma tissue samples analysed indicated a 1.75-fold change in the amount of S-phase kinase-associated protein 2, a 0.34-fold change in the amount of cyclin E and a 0.31-fold change in the amount of p27 protein, compared with positive controls. High levels of cyclin E significantly correlated with late-stage nasopharyngeal carcinoma (p = 0.009) and a poor overall survival (p = 0.010). Immunohistochemical analysis indicated positive expression of S-phase kinase-associated protein 2 in 16/29 nasopharyngeal tissue samples (55 per cent), of cyclin E in 13/29 samples (45 per cent) and of p27 protein in 17/29 (59 per cent) samples.


Overexpression of cyclin E messenger ribonucleic acid showed an adverse prognostic significance, correlating with an advanced stage of nasopharyngeal carcinoma and a low overall survival rate.


Corresponding author

Address for correspondence: Dr Chung-Feng Hwang, Department of Otolaryngology, Chang Gung Memorial Hospital – Kaohsiung Medical Center, Chang Gung University College of Medicine, 123 Ta-Pei Road, Niao-Sung Hsiang, Kaohsiung 833, Taiwan. Fax: +886 7 7313855 E-mail:


Hide All
1 Carrano, AC, Pagano, M. Role of the F-box protein Skp2 in adhesion-dependent cell cycle progression. J Cell Biol 2001;153:1381–90
2 Gstaiger, M, Jordan, R, Lim, M, Catzavelos, C, Mestan, J, Slingerland, J et al. Skp2 is oncogenic and overexpressed in human cancers. Proc Natl Acad Sci U S A 2001;98:5043–8
3 Tsvetkov, LM, Yeh, KH, Lee, SJ, Sun, H, Zhang, H. p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27. Curr Biol 1999;9:661–4
4 Carrano, AC, Eytan, E, Hershko, A, Pagano, M. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol 1999;1:193–9
5 Latres, E, Chiarle, R, Schulman, BA, Pavletich, NP, Pellicer, A, Inghirami, G et al. Role of the F-box protein Skp2 in lymphomagenesis. Proc Natl Acad Sci U S A 2001;98:2515–20
6 Chiarle, R, Fan, Y, Piva, R, Boggino, H, Skolnik, J, Novero, D et al. S-phase kinase-associated protein 2 expression in non-Hodgkin's lymphoma inversely correlates with p27 expression and defines cells in S phase. Am J Pathol 2002;160:1457–66
7 Yokoi, S, Yasui, K, Saito-Ohara, F, Koshikawa, K, Iizasa, T, Fujisawa, T et al. A novel target gene, SKP2, within the 5p13 amplicon that is frequently detected in small cell lung cancers. Am J Pathol 2002;161:207–16
8 Datta, MW, Renshaw, AA, Dutta, A, Hoffman, MA, Loughlin, KR. Evaluation of cyclin expression in testicular germ cell tumors: cyclin E correlates with tumor type, advanced clinical stage, and pulmonary metastasis. Mod Pathol 2000;13:667–72
9 Muller-Tidow, C, Metzger, R, Kugler, K, Diederichs, S, Idos, G, Thomas, M et al. Cyclin E is the only cyclin-dependent kinase 2-associated cyclin that predicts metastasis and survival in early stage non-small cell lung cancer. Cancer Res 2001;61:647–53
10 Vokes, EE, Liebowitz, DN, Weichselbaum, RR. Nasopharyngeal carcinoma. Lancet 1997;350:1087–91
11 Fandi, A, Altun, M, Azli, N, Armand, JP, Cvitkovic, E. Nasopharyngeal cancer: epidemiology, staging, and treatment. Semin Oncol 1994;21:382–97
12 Moore, C, Shen, XD, Gao, F, Busuttil, RW, Coito, AJ. Fibronectin-alpha4beta1 integrin interactions regulate metalloproteinase-9 expression in steatotic liver ischemia and reperfusion injury. Am J Pathol 2007;170:567–77
13 Mustafa, T, Klonisch, T, Hombach-Klonisch, S, Kehlen, A, Schmutzler, C, Koehrle, J et al. Expression of CD97 and CD55 in human medullary thyroid carcinomas. Int J Oncol 2004;24:285–94
14 Sobin, LH, Fleming, ID. TNM Classification of Malignant Tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 1997;80:1803–4
15 Hershko, D, Bornstein, G, Ben-Izhak, O, Carrano, A, Pagano, M, Krausz, MM et al. Inverse relation between levels of p27(Kip1) and of its ubiquitin ligase subunit Skp2 in colorectal carcinomas. Cancer 2001;91:1745–51
16 Kudo, Y, Kitajima, S, Sato, S, Miyauchi, M, Ogawa, I, Takata, T. High expression of S-phase kinase-interacting protein 2, human F-box protein, correlates with poor prognosis in oral squamous cell carcinomas. Cancer Res 2001;61:7044–7
17 Kim, JY, Lim, SJ, Kim, HJ, Shin, E, Park, K, Lee, CM. Clinical significance of p27 and Skp2 protein expression in uterine cervical neoplasm. Int J Gynecol Pathol 2007;26:242–7
18 Sui, L, Dong, Y, Watanabe, Y, Yamaguchi, F, Sugimoto, K, Tokuda, M. Clinical significance of Skp2 expression, alone and combined with Jab1 and p27 in epithelial ovarian tumors. Oncol Rep 2006;15:765–71
19 Fukuse, T, Hirata, T, Naiki, H, Hitomi, S, Wada, H. Prognostic significance of cyclin E overexpression in resected non-small cell lung cancer. Cancer Res 2000;60:242–4
20 Mishina, T, Dosaka-Akita, H, Hommura, F, Nishi, M, Kojima, T, Ogura, S et al. Cyclin E expression, a potential prognostic marker for non-small cell lung cancers. Clin Cancer Res 2000;6:1116
21 Brzezinski, J, Migodzinski, A, Gosek, A, Tazbir, J, Dedecjus, M. Cyclin E expression in papillary thyroid carcinoma: relation to staging. Int J Cancer 2004;109:102–5
22 Bani-Hani, KE, Almasri, NM, Khader, YS, Sheyab, FM, Karam, HN. Combined evaluation of expressions of cyclin E and p53 proteins as prognostic factors for patients with gastric cancer. Clin Cancer Res 2005;11:1447–53
23 Peters, MG, Vidal Mdel, C, Gimenez, L, Mauro, L, Armanasco, E, Cresta, C et al. Prognostic value of cell cycle regulator molecules in surgically resected stage I and II breast cancer. Oncol Rep 2004;12:1143–50
24 Baba, Y, Tsukuda, M, Mochimatsu, I, Furukawa, S, Kagata, H, Satake, K et al. Reduced expression of p16 and p27 proteins in nasopharyngeal carcinoma. Cancer Detect Prev 2001;25:414–19
25 Hwang, CF, Su, CY, Huang, SC, Huang, CC, Fang, FM, Lui, CC et al. Low expression levels of p27 correlate with loco-regional recurrence in nasopharyngeal carcinoma. Cancer Lett 2003;189:231–6
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

The Journal of Laryngology & Otology
  • ISSN: 0022-2151
  • EISSN: 1748-5460
  • URL: /core/journals/journal-of-laryngology-and-otology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *



Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed